Detalhe da pesquisa
1.
A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.
J Virol
; 95(9)2021 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33597214
2.
Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model.
Nat Commun
; 12(1): 3054, 2021 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031380
3.
Stimulation of B Cell Immunity in Flavivirus-Naive Individuals by the Tetravalent Live Attenuated Dengue Vaccine TV003.
Cell Rep Med
; 1(9): 100155, 2020 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33377126
4.
Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model.
EBioMedicine
; 41: 465-478, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30857944
5.
Human antibody response to Zika targets type-specific quaternary structure epitopes.
JCI Insight
; 4(8)2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30996133
6.
Corrigendum to ''Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model'' [EBioMedicine 41 (2019) 465-478].
EBioMedicine
; 54: 102708, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32251996